Biolase stock

Biolase stock Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. Palantir Technologies Inc. Class A Common Stock. $9.55 23.39%.2 analysts have issued twelve-month price objectives for BIOLASE's stock. Their BIOL share price forecasts range from $2.00 to $14.00. On average, they expect the company's stock price to reach …The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ...25malxhatch cantina 1 day ago · Biolase BIOL shares fell 42.3% to $0.08 during Wednesday's regular session. As of 13:30 EST, Biolase's stock is trading at a volume of 33.3 million, which is 2090.9% of its average full-day volume ... BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ...May 22, 2023 · What is Biolase Inc’s stock style? BIOL’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. Business Description. Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and ...May 22, 2023 · What is Biolase Inc’s stock style? BIOL’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable … what industry is amazon in The purchase price for one Unit is $26.00, which reflects the issuance of the Series H Convertible Preferred Stock with an original issue discount.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript March 28, 2023 Operator: Greetings. Welcome to the BIOLASE 2022 Fourth Quarter and Full Year …The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...1987. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform ... lotus cuisine of india The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.May 4, 2023 · BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ... 1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. cini's BIOLASE Stock Forecast and Price Target. The average price target for BIOLASE's stock set by recognized analysts recently is $2.00, which would result in a potential upside of approximately 455.56% if it reached this mark. The estimation is based on a high estimate of $3.00 and a low estimate of $1.50.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Jan 25, 202303:34 PST. BIOL. BIOLASE Inc BIOL: BIOLASE INC - VIEWS SONENDO'S CLAIMS AS "MERITLESS" AND INTENDS TO FIGHT THEM. Americas. blackseed bagels The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common …The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.We forecast BIOLASE stock performance using neural networks based on historical data on BIOLASE stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. BIOLASE stock prediction results are shown below and presented in the form of graphs, tables and text information, …BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ... desert wind coffee roasters BIOL Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. BIOLASE, INC. Compare. BIOLASE, ...BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript March 28, 2023 Operator: Greetings. Welcome to the BIOLASE 2022 Fourth ...Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. View the latest Biolase Inc. (BIOL) stock price, news, historical charts, analyst ratings and financial information from WSJ. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on …Should I buy Biolase (BIOL)? Use the Zacks Rank and Style Scores to find out is BIOL is right for your portfolio.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.While the company's business continues to show respectable growth, cash burn remains a major issue. At the current pace of cash usage, BIOLASE would have to raise additional capital in H2/2023 at ... lion group microvision BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and … chat bhavan1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. 1 day ago · Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ... May 22, 2023 · What is Biolase Inc’s stock style? BIOL’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index Fund: 167,042: Dec 30, 2022: 0.63%: 26,977: Vanguard Extended Market Index Fund: 92,558 kiku ya BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ...1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. Jan 25, 2023 · Jan 25, 202303:34 PST. BIOL. BIOLASE Inc BIOL: BIOLASE INC - VIEWS SONENDO'S CLAIMS AS "MERITLESS" AND INTENDS TO FIGHT THEM. Americas. 1 day ago · Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ... Jan 25, 202303:34 PST. BIOL. BIOLASE Inc BIOL: BIOLASE INC - VIEWS SONENDO'S CLAIMS AS "MERITLESS" AND INTENDS TO FIGHT THEM. Americas.BIOLASE Trading Down 39.9 %. Shares of BIOLASE stock opened at $0.08 on Wednesday. BIOLASE has a 1 year low of $0.07 and a 1 year high of $5.94. The company has a debt-to-equity ratio of 1.53, a current ratio of 1.68 and a quick ratio of 0.75. The firm has a fifty day moving average price of $0.26 and a 200 day moving average …1 day ago · Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ... Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in …BIOLASE, INC. Delaware 001-36385 87-0442441 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 27042 Towne Centre Drive, Suite 270 Lake ... gold miner etfBusiness Description. Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and ...On average, Wall Street analysts predict. that Biolase's share price could reach $1.50 by Mar 29, 2024. The average Biolase stock price prediction forecasts a potential upside of …BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ... dumpling xuan BIOLASE, INC. analysts consensus, targets, ratings and recommendations | Nasdaq: BIOL | NasdaqThe Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common …Business. The trading price of BIOLASE Inc. (NASDAQ:BIOL) closed lower on Monday, May 22, closing at $0.15, -4.40% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.148 and $0.174. In examining the 52-week price action we see that the stock hit a 52-week …Business Description. Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and ...1 day ago · Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ... Biolase stock price target cut to $11 from $14 at Ascendiant Capital Mar. 29, 2023 at 6:10 a.m. ET by Tomi Kilgore Biolase Shares Edge Down 5.9% Despite 2023 Revenue Guidance Above EstimatesBIOL Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. BIOLASE, INC. Compare. BIOLASE, ...Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...Some stocks are best avoided. We really hate to see fellow investors lose their hard-earned money. Spare a thought for those who held BIOLASE, Inc. (NASDAQ:BIOL) for five whole years - as the ...8 hours ago · BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ... Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index Fund: 167,042: Dec 30, 2022: 0.63%: 26,977: Vanguard Extended Market Index Fund: 92,5581 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. May 4, 2023 · BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ... Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued. pizza chief May 21, 2022 · Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued. Historical daily share price chart and data for Biolase since 1992 adjusted for splits. The latest closing stock price for Biolase as of May 18, 2023 is 0.16. The all-time high Biolase stock closing price was 2426.76 on January 21, 2004. The Biolase 52-week high stock price is 5.94, which is 3612.5% above the current share price.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. ninos greek cafe metro wings dbgiThe Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.1987. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform ...What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $7.00 with a high price target of $14.00 and a low price target of $2.00.BIOL Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. BIOLASE, INC. Compare. BIOLASE, ... hot dog on a stick near me Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.8 hours ago · BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ... the licking chicago The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.8 hours ago · BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ... kacha thai 1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. Business. The trading price of BIOLASE Inc. (NASDAQ:BIOL) closed lower on Monday, May 22, closing at $0.15, -4.40% lower than its previous close. Traders who …1 day ago · Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ... May 21, 2022 · Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued. biolase inc biol: biolase delivers 24% revenue growth in 2022 as go-to-market strategies gain momentum; guides for at least 25% revenue growth and profitability in 2023. q4 revenue rose 24 percent to $48.5 million. anticipating first-quarter net revenue to exceed $10.0 million. qtrly loss per share $1.28 1803 nyc ctra dividendMay 12, 2023 · Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...Business. The trading price of BIOLASE Inc. (NASDAQ:BIOL) closed lower on Monday, May 22, closing at $0.15, -4.40% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.148 and $0.174. In examining the 52-week price action we see that the stock hit a 52-week … meeples brew Immediately after the annual meeting, the Board of Directors approved the reverse stock split of BIOLASE's common stock, through an amendment to BIOLASE's charter, at a ratio of 1 post-split share for every 5 pre-split shares. The 1-for-5 reverse stock split will become effective at 11:59 p.m. ET on Thursday, May 10, 2018 (the "Effective …The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Business Description. Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and ... rodrigo taco shop 1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. May 12, 2023 · Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ...Should I buy Biolase (BIOL)? Use the Zacks Rank and Style Scores to find out is BIOL is right for your portfolio.BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ...Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ... el gallo dorado Today. $0.15. 0.0004. (0.26%) After Hours. Market Cap $4.48M. Volume (M) 2.12M. 52-Wk High $5.94. 52-Wk Low $0.0996.The purchase price for one Unit is $26.00, which reflects the issuance of the Series H Convertible Preferred Stock with an original issue discount.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. Find the latest BIOLASE, Inc. (BIOL) stock quote, history, news and other vital information to help you with your stock trading and investing. savonas red hook COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today ...On average, Wall Street analysts predict. that Biolase's share price could reach $1.50 by Mar 29, 2024. The average Biolase stock price prediction forecasts a potential upside of …May 22, 2023 · What is Biolase Inc’s stock style? BIOL’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. Find real-time BIOL - BIOLASE Inc stock quotes, company profile, news and forecasts from CNN Business.Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued. us dollar in ksh BIOLASE Stock Forecast and Price Target. The average price target for BIOLASE's stock set by recognized analysts recently is $2.00, which would result in a potential upside of approximately 455.56% if it reached this mark. The estimation is based on a high estimate of $3.00 and a low estimate of $1.50.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.1 day ago · LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference ... ark etf stock May 4, 2023 · BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ... 2 days ago · Biolase (NASDAQ: BIOL) shares are heading more than 15% higher after announcing a proposed offering. Lifecore Biomedical (NASDAQ: LFCR ) stock is climbing over 15% thanks to a refinancing deal . The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. valor do dolar no brasil nvosBIOL Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. BIOLASE, INC. Compare. BIOLASE, ...The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ... peso mexicano con el dolar May 4, 2023 · BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ... hong kong east ocean seafood restaurantBusiness Description. Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and ...8 hours ago · BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ... Today. $0.15. 0.0004. (0.26%) After Hours. Market Cap $4.48M. Volume (M) 2.12M. 52-Wk High $5.94. 52-Wk Low $0.0996.The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. p.s. gourmet coffee May 21, 2022 · Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued. Biolase Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.BIOL Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. BIOLASE, INC. Compare. BIOLASE, ... 1 day ago · Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ... Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. vegan donut gelato 1 day ago · LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference ... BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 0.1615 +0.0015 (+0.94%) At close: 04:00PM EDT. 0.1649 +0.00 (+2.11%) Pre-Market: 06:43AM EDT.8 hours ago · BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ... BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Business Description. Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and ... b2 bistro and bar 1987. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform ...May 21, 2022 · Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued. nasdaq abnb Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable …1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ...BIOL Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. BIOLASE, INC. Compare. BIOLASE, ... taqueria mas cercana Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in …The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close ... my indian pizzaCOMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today ...2 analysts have issued twelve-month price objectives for BIOLASE's stock. Their BIOL share price forecasts range from $2.00 to $14.00. On average, they expect the company's stock price to reach … sun shui kaiju eatsBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants LAKE FOREST, Calif. , May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an …Business Description. Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and ...Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Biolase Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. daily drip coffee and desserts BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and …1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable …The stock has a 50-day moving average price of $0.26 and a 200 day moving average price of $0.57. BIOLASE ( NASDAQ:BIOL – Get Rating) last issued its …Biolase Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.8 hours ago · BIOLASE, Inc. announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one warrant to purchase one-half of one share of Series H Convertible ... 1 day ago · The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398. 1 day ago · Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The ...